Toll Free: 1-888-928-9744
Published: Jul, 2014 | Pages:
18 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
VBI Vaccines - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'VBI Vaccines - Product Pipeline Review - 2014', provides an overview of the VBI Vaccines's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of VBI Vaccines's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of VBI Vaccines including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of VBI Vaccines's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the VBI Vaccines's pipeline products Reasons to buy - Evaluate VBI Vaccines's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of VBI Vaccines in its therapy areas of focus - Identify new drug targets and therapeutic classes in the VBI Vaccines's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of VBI Vaccines and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of VBI Vaccines - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of VBI Vaccines and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 VBI Vaccines Snapshot 4 VBI Vaccines Overview 4 Key Information 4 Key Facts 4 VBI Vaccines - Research and Development Overview 5 Key Therapeutic Areas 5 VBI Vaccines - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 VBI Vaccines - Pipeline Products Glance 9 VBI Vaccines - Early Stage Pipeline Products 9 Preclinical Products/Combination Treatment Modalities 9 VBI Vaccines - Drug Profiles 10 CMV Vaccine 10 Product Description 10 Mechanism of Action 10 R&D Progress 10 Vaccine For Infectious Diseases 11 Product Description 11 Mechanism of Action 11 R&D Progress 11 VBI-1502A 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 VBI Vaccines - Pipeline Analysis 13 VBI Vaccines - Pipeline Products by Route of Administration 13 VBI Vaccines - Pipeline Products by Molecule Type 14 VBI Vaccines - Dormant Projects 15 VBI Vaccines - Locations And Subsidiaries 16 Head Office 16 Other Locations & Subsidiaries 16 Appendix 17 Methodology 17 Coverage 17 Secondary Research 17 Primary Research 17 Expert Panel Validation 17 Contact Us 18 Disclaimer 18
List of Tables VBI Vaccines, Key Information 4 VBI Vaccines, Key Facts 4 VBI Vaccines - Pipeline by Indication, 2014 6 VBI Vaccines - Pipeline by Stage of Development, 2014 7 VBI Vaccines - Monotherapy Products in Pipeline, 2014 8 VBI Vaccines - Preclinical, 2014 9 VBI Vaccines - Pipeline by Route of Administration, 2014 13 VBI Vaccines - Pipeline by Molecule Type, 2014 14 VBI Vaccines - Dormant Developmental Projects,2014 15 VBI Vaccines, Other Locations 16
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.